Alzheimer’s disease: biological mechanisms, epigenetics, and emerging technologies for early diagnosis

Alzheimer’s disease: biological mechanisms, epigenetics, and emerging technologies for early diagnosis

Thursday, February 5, 2026 – 2:30 pm
Dipartimento di Neuroscienze “Rita Levi Montalcini” – Università di Torino
Aula Magna di Psichiatria (Aula Torre)
via Cherasco 11, piano terra

 

Alzheimer’s disease: biological mechanisms, epigenetics, and emerging technologies for early diagnosis

Presentation of research projects supported by the CRT Foundation (Ordinary Grants)

14.30  Welcome greetings
Prof. Alessandro Vercelli, Direttore del Dipartimento di Neuroscienze “Rita Levi Montalcini” e del NICO – Università di Torino 

Introduction
Moderators and PI : Proff. Michela Guglielmotto, Marco Sassoè Pognetto, Elisa Rubino, Serena Stanga – Dipartimento di Neuroscienze “Rita Levi Montalcini”, Università di Torino

14.40-15.00
Prof. Innocenzo Rainero, MD, PhD – Dipartimento di Neuroscienze “Rita Levi Montalcini”, Università di Torino
Alzheimer’s disease: toward the future of early diagnosis, therapy, and prevention

15.00-15.30
Dott.ssa Valentina Scarpetta, PhD – Dipartimento di Neuroscienze “Rita Levi Montalcini”, Università di Torino
The choroid plexus: morphological and functional changes during aging and in models of Alzheimer’s disease

15.30-16.00
Dr. Letizia Bergamasco, PhD – Politecnico di Torino
Artificial intelligence-based facial expression analysis to support early and differential diagnosis of dementia

16.00-16.20 Coffee break

16.20-16.50
Dr. Giulia Cicilese, PhD Student – Dipartimento di Neuroscienze “Rita Levi Montalcini”, NICO Neuroscience Institute Cavalieri Ottolenghi, Università di Torino
Study of early plasma biomarkers of Alzheimer’s disease: the role of miRNA-218

16.50-17.20
Prof. Serena Stanga, PhD – Dipartimento di Neuroscienze “Rita Levi Montalcini”, NICO Neuroscience Institute Cavalieri Ottolenghi, Università di Torino
Brain iron dyshomeostasis as a novel hallmark of early neurodegeneration in Alzheimer’s disease

Closing remarks

Ingresso libero fino a esaurimento dei posti disponibili

Supported by

Subscribe to our newsletter
Stay updated on news and projects

Subscribe to our newsletter
Stay updated on news and projects